ES
Eve Smith
University of Glasgow
Research areas: Medicine · Rheumatology · Systemic Lupus Erythematosus Research · Systemic Sclerosis and Related Diseases · Autoimmune and Inflammatory Disorders Research
0000-0002-8371-7597
Employment
-
University of Glasgow Senior Clinical Lecturer2025 - Present
Education
Education history is unavailable.
Projects & Funding
-
cSLE-T2T-GLOBAL: Childhood Systemic Lupus Erythematosus Treat-to-Target Analysis across Global Registries FOREUM / Rheumatology Research Foundation Collaborative EU/US Partnership Award2024 - 2026
-
NEPHROTARGET: Exploring Treat-to-Target and Urine Biomarker Monitoring in Lupus Nephritis affecting Children and Young People Alder Hey Children’s Kidney Fund2024 - 2025
-
FunctionMatters: co-creation of a comprehensive tool for assessing function and delivering personalized self-management support in Childhood Lupus Alder Hey Charity2023 - 2024
-
Digital solutions to improve the delivery of Treat to Target in cSLE Alder Hey Innovation iFACTOR Award2023 - 2024
-
Advancing towards a Treat to Target approach for Childhood Lupus Medical Research Foundation2023 - 2025
-
Funding for a full-time LUPUS UK Specialist Lupus Nurse (role 50% research: 50% clinical) at Alder Hey Children’s Hospital, Liverpool. LUPUS UK2022 - 2027
-
Identifying Cross-Registry Commonalities to Facilitate International Pediatric Lupus Research Paediatric Rheumatology European Society (PReS) / Childhood Arthritis and Rheumatology Research Alliance (CARRA)2021 - 2023
-
Quantification of interferon-α using ultrasensitive digital ELISA in Juvenile Systemic Lupus Erythematosus (JSLE), non-SLE inflammatory disease and healthy controls. University of Liverpool2020 - 2021
-
Development of a PPI group to inform the design of a paediatric patient reported measure of glucocorticoid toxicity. Wellcome Trust Public Engagement Grants2020 - 2021
-
Deriving the target(s) for a Juvenile-onset Systemic Lupus Erythematosus Treat to Target Study UK Paediatric Rheumatology Clinical Studies Group2019 - 2021
-
Deriving the target(s) for a Juvenile-onset Systemic Lupus Erythematosus Treat to Target Study Wellcome Trust Institutional Strategic Support Fund Equality and Diversity2019 - 2021
-
Genetic factors in juvenile-onset systemic lupus erythermatosus (jSLE): future guides for individualised treatment University of Liverpool Technology Directorate scheme2018 - 2019
-
British Paediatric Surveillance Unit (BPSU) study of the incidence and prevalence of JSLE in children and young people in the UK and Republic of Ireland – year 2 extension LUPUS UK2018 - 2020
-
British Paediatric Surveillance Unit (BPSU) study of incidence and prevalence JSLE in children and young people in UK and Republic of Ireland. LUPUS UK2016 - 2018
-
A urine biomarker panel for monitoring lupus nephritis: moving towards a single assay technique. Medical Research Council2015 - 2017
-
Alder Hey Children’s Kidney Fund travel award Alder Hey Children’s Kidney Fund2015 - 2016
-
Merck Millipore Magpix Grant program winner Merck (Germany)2015 - Present
-
Tracking cancer and mortality in UK Children and Young People with Lupus. Enabling linkage of the UK JSLE Cohort Study to the NHS Health and Social Care Information Centre. LUPUS UK2014 - 2025
-
‘Living with Lupus’ - developing treatment targets and outcome measures with children and young people to TARGET LUPUS Wellcome Trust
Publications (57)
- Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force Save
- Cardiovascular risk in young people with childhood onset systemic lupus erythematosus Save
- Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce Save
- Current views on lupus in children Save
- Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope Save
- PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS) Save
- Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE Save
- Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force Save
- Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus Save
- Comment on: Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?: Reply Save
- Improving communication of the concept of 'treat-to target' in childhood lupus: a public and patient (PPI) engagement project involving children and young people Save
- Longitudinal analysis of urinary proteins in lupus nephritis – A pilot study Save
- Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland Save
- Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study Save
- Research priority setting for paediatric rheumatology in the UK Save
- The importance of children and young person involvement in scoping the need for a paediatric glucocorticoid-associated patient reported outcome measure Save
- The importance of children and young person involvement in scoping the need for a paediatric glucocorticoid-associated patient reported outcome measure Save
- What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012? Save
- 'It is good to have a target in mind': Qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus Save
- A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment Save